Blue Horseshoe Stocks: Cannabis Reminder

Cannabis Reminder

With the cannabis counterculture holiday of 04/20 capping off this week on Friday, you can bet that our tracking of the cannabis sector is going to ramp up right along with many of these stocks.

It was back on the 4th of this month that we published an extensive list of marijuana industry stocks to track in anticipation of this event. For those outside the loop, “Four-Twenty” is a massive celebration each year on April 20th, to commemorate the cultural tradition of partaking in cannabis at 4:20pm on any given day. Cannabis companies use this as the perfect marketing ploy, and as a result, many do their highest sales of the year on the heels of this holiday.

A few of the plays we highlighted earlier this month have already begun to see appreciable moves on the chart. Take OWC Pharma (OWCP) for example. Since the 4th, the stock has increased from .20 to .30, a 50% rise in under two weeks.

We would expect to see similar, and even better gains coming from many cannabis stocks all across the board. That’s why we wanted to open up this week with a reminder to keep a close eye on anything even remotely tied to the space.

Just refresh, some of those stocks include, but are not limited to:

AGTK, HEMP, SGMD, SING, GRNE, GOHE, MCOA, MCIG, POTN, PNTV, RMHB, CANN, CBIS, ATTBF, GLDFF, GLNNF, NXTTF, MRRCF, SPRWF & CRON


Extended Watchlist:
SSC, NETE, ITCI, ERI, MBII, NAV, ONVO, LOXO, CLS

Incoming search terms:

  • is mcoa a good investment

Blue Horseshoe Stocks: Cannabis Roundup & More

Cannabis Roundup

We wanted to take some time out this midweek to get back to cannabis, the rapidly growing industry that we’ve always said we felt has as much or more potential than any other out there. The first quarter of the 2018 calendar year was rather low key, but with some major cannabis dates coming up, we wanted to sharpen our focus on the sector.

The 04/20 Holiday is generally a time when you see heightened visibility, and an influx of sales for recreational marijuana businesses. It’s the “Super Bowl” for many of these businesses, which will see their highest customer volume of the year.

It’s a time of increased awareness in the investment community for the space as a whole, and that’s why we wanted to refresh our running watchlist of pot stocks on our radar:

As for the ones based here in the U.S. some of our favorites (in no particular order) have been: OWCP, AGTK, HEMP, SGMD, SING, GRNE, GOHE, MCOA, MCIG, POTN, PNTV, RMHB, CANN and CBIS.

We also have July to look forward to, which marks the nationwide legalization of recreational marijuana in Canada, where some of the most impressive cannabis companies, like ACBFF and APHQF reside. Other notable Canadian players include ATTBF, GLDFF, GLNNF, NXTTF, MRRCF, SPRWF, and CRON.


Facebook, Inc. FB

We started off the week on Monday by signaling some options ideas, the FB Weekly $155-160 Calls. Despite a terrible start to the week for the markets as a whole, yesterday’s bounce-back helped began to provide us with the kind of moves we were looking for out of those plays.

In fact, each of three contracts in our designated range yielded the chance at multi-bag gains yesterday, with the following moves:

$155 Calls – Range: 1.55-4.27  – Max Gain: 175%
$157.50 Calls – Range: .90-2.75 – Max Gain: 205%
$160 Calls – Range: .49-1.69 – Max Gain: 245%


Extended Watchlist:
WLB, ASTC, HCC, EGO, TCAP, AQMS

Blue Horseshoe Stocks: NEPT Review & More

Neptune Technology & Bioresources, Inc. NEPT

To start off the new calendar year on a high note, we’d like to track back to a stock we placed on our radars on the morning of November 28th, and recap the solid bullish performance that followed.

NEPT has been in a general uptrend ever since our alert, and is showing a strong sign that it may continue. Subsequent to our initial report, we observed a low of 1.30 in the stock, and as of the new high achieved to close out last week at 2.44. it marked an increase of 88%

We’ll continue to observe this stock, and will want to see it maintain support at or above the 2.20-area on any pullbacks.


INSYS Therapeutics, Inc. INSY

We formulated an options trading idea for the INSY 01/19 $8 and $9 Calls on Wednesday morning, and on Friday. mentioned that despite only moderate gains in the previous session, that we’d still be looking for our opportunity to come along.

Friday’s session facilitated some solid moves in our highlighted contracts, and current conditions suggest we could see an extension to the already significant gains that were there for the taking to close out the 2017 trading year.

The $8 Calls ran from .90-2.27, for a gain of 152%, while the $9′s traded up from .60 to 1.51, which works out to a 151% move.

INSY has traded as high as 10.25 in premarket trading today, and we will look to roll up our strike price to the $10-level if the stock holds above this morning’s premarket low of  9.75 once the session gets rolling.


Extended Watchlist:
TEUM, WATT, SBGL, SSC, MCIG, AGTK, GLDFF, VPER

Incoming search terms:

  • 6IGH
  • churchbj2
  • IOKY
  • sbgl premarket
  • teethtne
  • tobaccofgn
  • ZQWB

Blue Horseshoe Stocks: Cannabis Sector Heating Up Again

Cannabis Comments

We got head-faked a little bit in terms of the cannabis sector in the past year or so. Leading up to last fall, anything even remotely tied to marijuana was going through the roof, with seemingly no end in sight. Then a regime change in Washington led to the appointment of self-avowed cannabis hater Jeff Sessions to the head of the DOJ. That led to a considerable cooling of what was previously the hottest market sector.

That being said, it has been business as usual for companies operating in the space in places that have taken the step of ending prohibition. Growth is happening all around, and the investment community has taken notice. The cannabis sector is showing signs of heating up once again, so we want to return to some of the plays we’ve covered in the past and highlight a few that could stand to see some good moves in the days and weeks ahead.

Dewmar International, Inc. DEWM – We just signaled our interest in DEWM in Friday morning’s premarket report, and the stock made a solid two-session swing. From Friday’s low of .0108 to .0163 yesterday, marking a move of 51% We’ll want to continue to track its movements,particularly after this morning’s news.

DEWM announced today that it filed a provisional patent with the US Patent and Trademark Office for the treatment of lung cancer with cannabinoids, so that’s going to be another interesting storyline to follow with respect to DEWM.
_____

Also going on our refreshed cannabis watchlist of previously tracked stocks will be PNTV, POTN, MCIG, MCOA, and TRTC.


Netflix, Inc. NFLX – Options

We’re always looking for a good post-earnings options play and we may have one with NFLX this morning. Up 10% in premarket trading on a solid beat, we’re going to be looking for a potential dip-and-rip scenario that could lead to some hefty intraday moves. Our targets are going to be the NFLX Weekly $172.50-180 Calls.


Extended Watchlist:
CAPR, MBRX, MDGS, NVAX, OPK OPCO, TTOO, RAD

Blue Horseshoe Stocks: News Plays & Special Reminder

Aeterna Zentaris, Inc. AEZS

AEZS is gapping up this morning on the heels of some news. It’s been quite a few months since we last mentioned this stock. That was back in the fall, and we subsequently witnessed quite a surge from the stock after that.

Since then, so far in 2017 the stock has come down to record new annual lows, and recently has been making incremental increases off of that bottom. In light of today’s news, described below, we think it’s a good time to put AEZS back on a more intensive watch.

The company announced this morning, following a comprehensive review Phase 3 clinical data on Macrilen™ for the evaluation of growth hormone deficiency, that Macrilen™ demonstrated performance supportive of achieving registration with the FDA. The FDA has agreed to consider the Company’s conclusions during a Type A meeting, which is currently being scheduled. (>>View PR)


Zosano Pharma Corp. ZSAN

Speaking of fresh news plays, we also want to highlight the announcement coming from ZSAN this morning that presently has the stock gapping up in the premarket to the tune of 50%

This morning ZSAN reported that in its ZOTRIP pivotal efficacy study, the company’s M207 transdermal migraine therapy patch met both primary, as well as secondary endpoints. It certainly explains the premarket hoopla, and warrants our observation as we kick off a new trading week.

The chart also has some attractive features which we’ve pointed out on the snapshot below:


**SPECIAL REMINDER**

To wrap things up this morning, we want to leave our readers with a quick heads up on a big Tuesday coming up. We’ve got a special report coming out tomorrow prior to the opening bell. It could represent quite an opportunity, so tomorrow is definitely not the day to miss out on our premarket report!

Be sure to stay locked onto your email inboxes or BlueHorseshoeStocks.com tomorrow between 9:00 to 9:15AM, and lean on those refresh buttons!


Extended Watchlist:
MCIG, MYHI, ADVT, MJTK, QSIM, NK